Role of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI)

E Ettorre1, E Cerra, B Marigliano

  • 1Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences Sapienza University of Rome, Umberto I, Policlinico di Roma. Viale del Policlinico 155, I-00161 Roma, Italy.

Insights

Controlling cardiovascular risk factors (CRF) significantly impacts cognitive decline in mild cognitive impairment (MCI). Patients with MCI and CRF progress to Alzheimer

Area of Science:

  • Neurology
  • Geriatrics
  • Public Health

Background:

  • Limited therapeutic options exist for Alzheimer's disease (AD).
  • Evidence suggests controlling vascular risk factors may modify AD progression.
  • Cardiovascular risk factors (CRF) are increasingly recognized as potential contributors to cognitive decline.

Purpose of the Study:

  • To investigate the role of CRF in patients with mild cognitive impairment (MCI).
  • To evaluate the influence of CRF on cognitive and behavioral features in MCI.
  • To assess the impact of CRF on the progression from MCI to dementia.

Main Methods:

  • Study included 50 patients diagnosed with MCI using Petersen's criteria.
  • Patients were assessed for the presence of cardiovascular risk factors (CRF).
  • Cognitive status, behavioral features, and progression to dementia were monitored over time.

Main Results:

  • 60% of MCI patients with CRF progressed to dementia, versus 32% without CRF.
  • MCI patients with CRF exhibited worse cognitive performance.
  • MCI patients with CRF also showed increased behavioral disorders, depression, and functional disability.

Conclusions:

  • Cardiovascular risk factors play a key role in the cognitive decline of MCI patients.
  • MCI patients with CRF have a higher conversion rate to AD.
  • Early management of CRF may be crucial for mitigating cognitive decline in MCI.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...